Claraphi Advisory Network, LLC Repligen Corp Transaction History

Claraphi Advisory Network, LLC

  • $248 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$165.87 - $220.95 $507,064 - $675,444
-3,057 Closed
0 $0
Q1 2021

Apr 30, 2021
BUY
$180.37 - $226.26 $121,208 - $152,046
672 Added 28.18%
3,057 $594,000
Q4 2020

Feb 05, 2021
BUY
$148.08 - $206.57 $353,170 - $492,669
2,385 New
2,385 $457,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.99B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email